Soyfoods, hyperuricemia and gout: A review of the epidemiologic and clinical data

Asia Pacific Journal of Clinical Nutrition

Volumn 20, Issue 3, 2011, Pages 347-358

  Messina, Mark ^a   Messina, Virginia L ^a   Chan, Pauline ^b  

^a Department of Nutrition   (United States)

^b NONE   (Singapore)

Author keywords

Gout; Hyperuricemia; Soy; Uric acid; Vegetarian

Indexed keywords

GLYCINE MAX;

URIC ACID;

ASIA; BLOOD; DIET; GOUT; HEALTH PERSONNEL ATTITUDE; HUMAN; HYPERURICEMIA; METHODOLOGY; PREVALENCE; REVIEW; RISK FACTOR; SOYBEAN;

ASIA; ATTITUDE OF HEALTH PERSONNEL; DIET; GOUT; HUMANS; HYPERURICEMIA; PREVALENCE; RISK FACTORS; SOY FOODS; URIC ACID;

EID: 80053619562     PISSN: 09647058     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (138)

1. Messina M, Lane B. Soy protein, soybean isoflavones, and coronary heart disease risk: Where do we stand? Future Lipidol. 2007;2:55-74.
2. Li SH, Liu XX, Bai YY, Wang XJ, Sun K, Chen JZ, Hui RT. Effect of oral isoflavone supplementation on vascular endothelial function in postmenopausal women: a metaanalysis of randomized placebo-controlled trials. Am J Clin Nutr. 2010;91:480-6.
3. Coxam V. Phyto-oestrogens and bone health. Proc Nutr Soc. 2008;67:184-95.
4. Koh WP, Wu AH, Wang R, Ang LW, Heng D, Yuan JM, Yu MC. Gender-specific associations between soy and risk of hip fracture in the Singapore Chinese Health Study. Am J Epidemiol. 2009;170:901-9.
5. Zhang X, Shu XO, Li H, Yang G, Li Q, Gao YT, Zheng W. Prospective cohort study of soy food consumption and risk of bone fracture among postmenopausal women. Arch Intern Med. 2005;165:1890-5.
6. Wu AH, Yu MC, Tseng CC, Pike MC. Epidemiology of soy exposures and breast cancer risk. Br J Cancer. 2008;98:9-14.
7. Messina M, Wu AH. Perspectives on the soy-breast cancer relation. Am J Clin Nutr. 2009;89:1673S-9.
8. Messina M, Hilakivi-Clarke L. Early intake appears to be the key to the proposed protective effects of soy intake against breast cancer. Nutr Cancer. 2009;61:792-8.
9. Yan L, Spitznagel EL. Soy consumption and prostate cancer risk in men: a revisit of a meta-analysis. Am J Clin Nutr. 2009;89:1155-63.
10. Xu L, Ding Y, Catalona WJ, Yang XJ, Anderson WF, Jovanovic B et al. MEK4 function, genistein treatment, and invasion of human prostate cancer cells. J Natl Cancer Inst. 2009;101:1141-55.
11. Franke AA, Custer LJ, Wang W, Shi CY. HPLC analysis of isoflavonoids and other phenolic agents from foods and from human fluids. Proc Soc Exp Biol Med. 1998;217:263-73.
12. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology. 1998;139:4252-63.
13. Oseni T, Patel R, Pyle J, Jordan VC. Selective estrogen receptor modulators and phytoestrogens. Planta Med. 2008;74:1656-65.
14. Reiter E, Beck V, Medjakovic S, Jungbauer A. Isoflavones are safe compounds for therapeutical applications - evaluation of in vitro data. Gynecol Endocrinol. 2009;25:554-80.
15. Messina MJ. Legumes and soybeans: overview of their nutritional profiles and health effects. Am J Clin Nutr. 1999;70:439S-50.
16. Rand WM, Pellett PL, Young VR. Meta-analysis of nitrogen balance studies for estimating protein requirements in healthy adults. Am J Clin Nutr. 2003;77:109-27.
17. Slavin M, Kenworthy W, Yu LL. Antioxidant properties, phytochemical composition, and antiproliferative activity of Maryland-grown soybeans with colored seed coats. J Agric Food Chem. 2009;57:11174-85.
18. Messina M, Nagata C, Wu AH. Estimated Asian adult soy protein and isoflavone intakes. Nutr Cancer. 2006;55:1-12.
19. Karyadi D, Lukito W. Beneficial effects of tempeh in disease prevention and treatment. Nutr Rev. 1996;54:S94-8.
20. Lyu LC, Hsu CY, Yeh CY, Lee MS, Huang SH, Chen CL. A case-control study of the association of diet and obesity with gout in Taiwan. Am J Clin Nutr. 2003;78:690-701.
21. Chang H-J. A study on the farmer's life style and dietary habits of the hyperuricemia patients and their recognition on the symptom of gouty arthritis. J Chin Nutr Soc. 1991;16:191-209.
22. Jordan KM, Cameron JS, Snaith M, Zhang W, Doherty M, Seckl J, Hingorani A, Jaques R, Nuki G. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout. Rheumatology (Oxford). 2007;46:1372-4.
23. World Health Organization Regional Office for the Western Pacific. Development of food-based dietary guidelines for the Western Pacific region; 1999.
24. Richette P, Bardin T. Gout. Lancet. 2010;375:318-28.
25. Kramer HM, Curhan G. The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988-1994. Am J Kidney Dis. 2002;40:37-42.
26. Pascual E, Batlle-Gualda E, Martinez A, Rosas J, Vela P. Synovial fluid analysis for diagnosis of intercritical gout. Ann Intern Med. 1999;131:756-9.
27. Pelaez-Ballestas I, Hernandez Cuevas C, Burgos-Vargas R, Hernandez Roque L, Teran L, Espinoza J et al. Diagnosis of chronic gout: evaluating the American College of Rheumatology proposal, European league against rheumatism recommendations, and clinical judgment. J Rheumatol. 2010;37:1743-8.
28. Min SI, Yun IJ, Kang JM, Park YJ, Min SK, Ahn C, Kim SJ, Ha J. Moderate-to-severe early-onset hyperuricaemia: a prognostic marker of long-term kidney transplant outcome. Nephrol Dial Transplant. 2009;24:2584-90.
29. CDC NHANES 2003-04: Laboratory Procedure Manual. [cited 2010/4/11]; Available from http://www.cdc.gov/nchs/data/nhanes/nhanes_03_04/l40_c_met_uric_acid.pdf.
30. Chen LX, Schumacher HR. Gout: an evidence-based review. J Clin Rheumatol. 2008;14:S55-62.
31. Loeb JN. The influence of temperature on the solubility of monosodium urate. Arthritis Rheum. 1972;15:189-92.
32. Wu XW, Muzny DM, Lee CC, Caskey CT. Two independent mutational events in the loss of urate oxidase during hominoid evolution. J Mol Evol. 1992;34:78-84.
33. Oda M, Satta Y, Takenaka O, Takahata N. Loss of urate oxidase activity in hominoids and its evolutionary implications. Mol Biol Evol. 2002;19:640-53.
34. Johnson RJ, Titte S, Cade JR, Rideout BA, Oliver WJ. Uric acid, evolution and primitive cultures. Semin Nephrol. 2005;25:3-8.
35. Eggebeen AT. Gout: an update. Am Fam Physician. 2007; 76:801-8.
36. Vitart V, Rudan I, Hayward C, Gray NK, Floyd J, Palmer CN et al. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet. 2008;40:437-42.
37. Wu EQ, Patel PA, Mody RR, Yu AP, Cahill KE, Tang J, Krishnan E. Frequency, risk, and cost of gout-related episodes among the elderly: does serum uric acid level matter? J Rheumatol. 2009;36:1032-40.
38. Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med. 1987;82:421-6.
39. Schlesinger N. Dietary factors and hyperuricaemia. Curr Pharm Des. 2005;11:4133-8.
40. Nuki G, Simkin PA. A concise history of gout and hyperuricemia and their treatment. Arthritis Res Ther. 2006;8(S1): S1.
41. Garrod AB. A Treatise on Gout and Rheumatic Gout (Rheumatoid Arthritis). 3rd ed. London: Longmans, Green; 1876.
42. Snaith ML. Gout: diet and uric acid revisited. Lancet. 2001;358:525.
43. Wrotmann RL. Arthritis and allied conditions: a textbook of rheumatology. 13th ed. In: Koopman WJ, editors. Lippincott Williams and Williams; 1997. pp. 2078.
44. Kim KY, Ralph Schumacher H, Hunsche E, Wertheimer AI, Kong SX. A literature review of the epidemiology and treatment of acute gout. Clin Ther. 2003;25:1593-617.
45. Smith GW, Wright V. Allopurinol. Br J Clin Pract. 1987;41:710-1.
46. Shulten P, Thomas J, Miller M, Smith M, Ahern M. The role of diet in the management of gout: a comparison of knowledge and attitudes to current evidence. J Hum Nutr Diet. 2009;22:3-11.
47. Hayman S, Marcason W. Gout: is a purine-restricted diet still recommended? J Am Diet Assoc. 2009;109:1652.
48. Peixoto MR, Monego ET, Jardim PC, Carvalho MM, Sousa AL, Oliveira JS, Balestra Neto O. Diet and medication in the treatment of hyperuricemia in hypertensive patients. Arq Bras Cardiol. 2001;76:463-72.
49. Sutaria S, Katbamna R, Underwood M. Effectiveness of interventions for the treatment of acute and prevention of recurrent gout--a systematic review. Rheumatology (Oxford). 2006;45:1422-31.
50. Choi HK, Liu S, Curhan G. Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey. Arthritis Rheum. 2005;52:283-9.
51. Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Alcohol intake and risk of incident gout in men: a prospective study. Lancet. 2004;363:1277-81.
52. Huang HY, Appel LJ, Choi MJ, Gelber AC, Charleston J, Norkus EP, Miller ER 3rd. The effects of vitamin C supplementation on serum concentrations of uric acid: results of a randomized controlled trial. Arthritis Rheum. 2005;52:1843-7.
53. Choi HK, Gao X, Curhan G. Vitamin C intake and the risk of gout in men: a prospective study. Arch Intern Med. 2009;169:502-7.
54. Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med. 2004;350:1093-103.
55. Choi HK, Curhan G. Coffee consumption and risk of incident gout in women: the Nurses' Health Study. Am J Clin Nutr. 2010;92:922-7.
56. Choi HK. A prescription for lifestyle change in patients with hyperuricemia and gout. Curr Opin Rheumatol. 2010;22:165-72.
57. Livesey G. Fructose ingestion: dose-dependent responses in health research. J Nutr. 2009;139:1246S-52S.
58. Sun SZ, Flickinger BD, Williamson-Hughes PS, Empie MW. Lack of association between dietary fructose and hyperuricemia risk in adults. Nutr Metab (Lond). 2010;7: 16.
59. Choi HK, Willet W, Curhan G. Fructose-rich beverages and risk of gout in women. J Am Med Assoc. 2010;304: E1-9.
60. Clifford AJ, Riumallo JA, Young VR, Scrimshaw AS. Effect of oral purines on serum and urinary uric acid of normal, hyperuricemic and gouty humans. J Nutr. 1976;106:428-34.
61. Sarwar G, Brule D. Assessment of the uricogenic potential of processed foods based on the nature and quantity of dietary purines. Prog Food Nutr Sci. 1991;15:159-81.
62. Brule D, Sarwar G, Savoie L, Campbell J, Van Zeggelaar M. Differences in uricogenic effects of dietary purine bases, nucleosides and nucleotides in rats. J Nutr. 1988;118:780-6.
63. Waslien CI, Calloway DH, Margen S. Uric acid production of men fed graded amounts of egg protein and yeast nucleic acid. Am J Clin Nutr. 1968;21:892-7.
64. Fellstrom B, Danielson BG, Karlstrom B, Lithell H, Ljunghall S, Vessby B. The influence of a high dietary intake of purine-rich animal protein on urinary urate excretion and supersaturation in renal stone disease. Clin Sci. 1983;64:399-405.
65. Adams PF, Hendershot GE, Marano MA. Current estimates from the National Health Interview Survey, 1996. Vital Health Stat. 1999;10:1-203.
66. Arromdee E, Michet CJ, Crowson CS, O'Fallon WM, Gabriel SE. Epidemiology of gout: is the incidence rising? J Rheumatol. 2002;29:2403-6.
67. Wallace KL, Riedel AA, Joseph-Ridge N, Wortmann R. Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol. 2004;31:1582-7.
68. Annemans L, Spaepen E, Gaskin M, Bonnemaire M, Malier V, Gilbert T, Nuki G. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005. Ann Rheum Dis. 2008;67:960-6.
69. Harris CM, Lloyd DC, Lewis J. The prevalence and prophylaxis of gout in England. J Clin Epidemiol. 1995;48:1153-8.
70. Lawrence RC, Hochberg MC, Kelsey JL, McDuffie FC, Medsger TA Jr, Felts WR, Shulman LE. Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States. J Rheumatol. 1989;16:427-41.
71. Wijnands JM, Boonen A, Arts IC, Dagnelie PC, Stehouwer CD, van der Linden S. Large Epidemiologic Studies of Gout: Challenges in Diagnosis and Diagnostic Criteria. Curr Rheumatol Rep. 2011;13:167-74.
72. James PT, Leach R, Kalamara E, Shayeghi M. The worldwide obesity epidemic. Obes Res. 2001;9(S4):228S-33.
73. Fang W, Zeng X, Li M, Chen LX, Schumacher HR Jr, Zhang F. The management of gout at an academic healthcare center in Beijing: a physician survey. J Rheumatol. 2006;33:2041-9.
74. Chen S, Du H, Wang Y, Xu L. The epidemiology study of hyperuricemia and gout in a community population of Huangpu District in Shanghai. Chin Med J Engl. 1998;111:22 8-30.
75. Fang Q, Chen HZ, Yu ZF. Survey of uric acid among healthy Chinese and its relation to blood lipids. Zhonghua Nei Ke Za Zhi. 1983;22:434-48. (In Chinese).
76. Hakoda M. Epidemiology of hyperuricemia and gout in Japan. Nippon Rinsho. 2008;66:647-52.
77. Zeng Q, Wang Q, Chen R, Xiao Z, Huang S, Xu J. Primary gout in Shantou: a clinical and epidemiological study. Chin Med J (Engl). 2003;116:66-9.
78. Miao Z, Li C, Chen Y, Zhao S, Wang Y, Wang Z et al. Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China. J Rheumatol. 2008;35:1859-64.
79. Villegas R, Xiang YB, Cai Q, Fazio S, Linton M, Li H, Elasy T, Zheng W, Shu XO. Prevalence and determinants of hyperuricemia in middle-aged, urban Chinese men. Metab Syndr Relat Disord. 2010;8:263-70.
80. Nan H, Qiao Q, Dong Y, Gao W, Tang B, Qian R, Tuomilehto J. The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China. J Rheumatol. 2006;33:1346-50.
81. Chang HY, Pan WH, Yeh WT, Tsai KS. Hyperuricemia and gout in Taiwan: results from the Nutritional and Health Survey in Taiwan (1993-96). J Rheumatol. 2001;28:1640-6.
82. Lin SD, Tsai D, H, Hsu SR. Association between serum uric acid level and components of the metabolic syndrome. J Chin Med Assoc. 2006;69:512-6.
83. Lee MS, Lin SC, Chang HY, Lyu LC, Tsai KS, Pan WH. High prevalence of hyperuricemia in elderly Taiwanese. Asia Pac J Clin Nutr. 2005;14:285-92.
84. Yu KH, Luo SF. Younger age of onset of gout in Taiwan. Rheumatology (Oxford). 2003;42:166-70.
85. Darmawan J, Valkenburg HA, Muirden KD, Wigley RD. The epidemiology of gout and hyperuricemia in a rural population of Java. J Rheumatol. 1992;19:1595-9.
86. Ouppatham S, Bancha S, Choovichian P. The relationship of hyperuricemia and blood pressure in the Thai army population. J Postgrad Med. 2008;54:259-62.
87. Ryu S, Song J, Choi BY, Lee SJ, Kim WS, Chang Y, Kim DI, Suh BS, Sung KC. Incidence and risk factors for metabolic syndrome in Korean male workers, ages 30 to 39. Ann Epidemiol. 2007;17:245-52.
88. Pan WH, Chin CJ, Sheu CT, Lee MH. Hemostatic factors and blood lipids in young Buddhist vegetarians and omnivores. Am J Clin Nutr. 1993;58:354-9.
89. Yu KH, See LC, Huang YC, Yang CH, Sun JH. Dietary factors associated with hyperuricemia in adults. Semin Arthritis Rheum. 2008;37:243-50.
90. Liu B, Qin L, Liu A, Uchiyama S, Ueno T, Li X, Wang P. Prevalence of the equol-producer phenotype and its relationship with dietary isoflavone and serum lipids in healthy Chinese Adults. J Epidemiol. 2010;20:377-84.
91. Chang WC. Dietary intake and the risk of hyperuricemia, gout and chronic kidney disease in elderly Taiwanese men. Aging Male. 2010. (In press).
92. Villegas R, Xiang YB, Elasy T, Xu WH, Cai H, Cai Q, Linton MF, Fazio S, Zheng W, Shu XO. Purine-rich foods, protein intake, and the prevalence of hyperuricemia: The Shanghai Men's Health Study. Nutr Metab Cardiovasc Dis. 2011. (In press).
93. Liu B, Qin L, Liu A, Uchiyama S, Ueno T, Li X, Wang P. Prevalence of the equol-producer phenotype and its relationship with dietary isoflavone and serum lipids in healthy Chinese adults. J Epidemiol. 2010;20:377-84.
94. Kuo CS, Lai NS, Ho LT, Lin CL. Insulin sensitivity in Chinese ovo-lactovegetarians compared with omnivores. Eur J Clin Nutr. 2004;58:312-6.
95. Lin CK, Lin DJ, Yen CH, Chen SC, Chen CC, Wang TY, Chou MC, Chang HR, Lee MC. Comparison of renal function and other health outcomes in vegetarians versus omnivores in Taiwan. J Health Popul Nutr. 2010;28:470-5.
96. Ball MJ, Bartlett MA. Dietary intake and iron status of Australian vegetarian women. Am J Clin Nutr. 1999;70:353-8.
97. Breslau NA, Brinkley L, Hill KD, Pak CY. Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism. J Clin Endocrinol Metab. 1988;66:140-6.
98. Yamakita J, Yamamoto T, Moriwaki Y, Takahashi S, Tsutsumi Z, Higashino K. Effect of Tofu (bean curd) ingestion and on uric acid metabolism in healthy and gouty subjects. Adv Exp Med Biol. 1998;431:839-42.
99. Garrel DR, Verdy M, PetitClerc C, Martin C, Brule D, Hamet P. Milk- and soy-protein ingestion: acute effect on serum uric acid concentration. Am J Clin Nutr. 1991;53:665-9.
100. Brule D, Sarwar G, Savoie L. Changes in serum and urinary uric acid levels in normal human subjects fed purinerich foods containing different amounts of adenine and hypoxanthine. J Am Coll Nutr. 1992;11:353-8.
101. Dalbeth N, Wong S, Gamble GD, Horne A, Mason B, Pool B et al. Acute effect of milk on serum urate concentrations: a randomised controlled crossover trial. Ann Rheum Dis. 2010;69:1677-82.
102. Roch-Ramel F, Guisan B. Renal transport of urate in humans. News Physiol Sci. 1999;14:80-4.
103. Fulgoni VL, 3rd. Current protein intake in America: analysis of the National Health and Nutrition Examination Survey, 2003-2004. Am J Clin Nutr. 2008;87:1554S-7.
104. Cicero AF, Minardi M, Mirembe S, Pedro E, Gaddi A. Effects of a new low dose soy protein/beta-sitosterol association on plasma lipid levels and oxidation. Eur J Nutr. 2004;43:319-22.
105. Vuorinen-Markkola H, Yki-Jarvinen H. Hyperuricemia and insulin resistance. J Clin Endocrinol Metab. 1994;78:25-9.
106. Reaven GM. Syndrome X: 6 years later. J Intern Med Suppl. 1994;736:13-22.
107. Reaven GM, Chen YD, Jeppesen J, Maheux P, Krauss RM. Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. J Clin Invest. 1993;92:141-6.
108. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2010;62:170-80.
109. Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum. 2009;61:885-92.
110. See LC, Kuo CF, Chuang FH, Shen YM, Ko YS, Chen YM, Yu KH. Hyperuricemia and metabolic syndrome: associations with chronic kidney disease. Clin Rheumatol. 2011;30:323-30.
111. See LC, Kuo CF, Chuang FH, Shen YM, Ko YS, Chen YM, Yu KH. Hyperuricemia and metabolic syndrome: associations with chronic kidney disease. Clin Rheumatol. 2011;30:323-30.
112. Krishnan E, Kwoh CK, Schumacher HR, Kuller L. Hyperuricemia and incidence of hypertension among men without metabolic syndrome. Hypertension. 2007;49:298-303.
113. Puig JG, Martinez MA. Hyperuricemia, gout and the metabolic syndrome. Curr Opin Rheumatol. 2008;20:187-91.
114. Choi HK, Ford ES, Li C, Curhan G. Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Rheum. 2007;57:109-15.
115. Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidantand radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A. 1981;78:6858-62.
116. Becker BF, Reinholz N, Leipert B, Raschke P, Permanetter B, Gerlach E. Role of uric acid as an endogenous radical scavenger and antioxidant. Chest. 1991;100:176S-81.
117. Sautin YY, Johnson RJ. Uric acid: the oxidant-antioxidant paradox. Nucleosides Nucleotides Nucleic Acids. 2008;27:608-19.
118. Kontessis P, Jones S, Dodds R, Trevisan R, Nosadini R, Fioretto P, Borsato M, Sacerdoti D, Viberti G. Renal, metabolic and hormonal responses to ingestion of animal and vegetable proteins. Kidney Int. 1990;38:136-44.
119. D'Amico G, Gentile MG. Effect of dietary manipulation on the lipid abnormalities and urinary protein loss in nephrotic patients. Miner Electrolyte Metab. 1992;18:203-6.
120. Kontessis PA, Bossinakou I, Sarika L, Iliopoulou E, Papantoniou A, Trevisan R, Roussi D, Stipsanelli K, Grigorakis S, Souvatzoglou A. Renal, metabolic, and hormonal responses to proteins of different origin in normotensive, nonproteinuric type I diabetic patients. Diabetes Care. 1995;18:1233-40.
121. Guijarro C, Keane WF. Lipid-induced glomerular injury. Nephron. 1994;67:1-6.
122. Fried LF, Orchard TJ, Kasiske BL. Effect of lipid reduction on the progression of renal disease: a meta- analysis. Kidney Int. 2001;59:260-9.
123. Anderson JW, Blake JE, Turner J, Smith BM. Effects of soy protein on renal function and proteinuria in patients with type 2 diabetes. Am J Clin Nutr. 1998;68:1347S-53.
124. Soroka N, Silverberg DS, Greemland M, Birk Y, Blum M, Peer G, Iaina A. Comparison of a vegetable-based (soya) and an animal-based low-protein diet in predialysis chronic renal failure patients. Nephron. 1998;79:173-80.
125. Teixeira SR, Tappenden KA, Carson L, Jones R, Prabhudesai M, Marshall WP, Erdman JW, Jr. Isolated soy protein consumption reduces urinary albumin excretion and improves the serum lipid profile in men with type 2 diabetes mellitus and nephropathy. J Nutr. 2004;134:1874-80.
126. Bernstein AM, Treyzon L, Li Z. Are high-protein, vegetable- based diets safe for kidney function? A review of the literature. J Am Diet Assoc. 2007;107:644-50.
127. Anderson JW. Beneficial effects of soy protein consumption for renal function. Asia Pac J Clin Nutr. 2008;17(S1):324-8.
128. Azadbakht L, Kimiagar M, Mehrabi Y, Esmaillzadeh A, Padyab M, Hu FB, Willett WC. Soy inclusion in the diet improves features of the metabolic syndrome: a randomized crossover study in postmenopausal women. Am J Clin Nutr. 2007;85:735-41.
129. Ramsden CE, Hibbeln JR, Majchrzak SF, Davis JM. n-6 Fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a metaanalysis of randomised controlled trials. Br J Nutr. 2010;104:1586-600.
130. Harland JI, Haffner TA. Systematic review, meta-analysis and regression of randomised controlled trials reporting an association between an intake of circa 25 g soya protein per day and blood cholesterol. Atherosclerosis. 2008;200:13-27.
131. Zhan S, Ho SC. Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr. 2005;81:397-408.
132. Weggemans RM, Trautwein EA. Relation between soyassociated isoflavones and LDL and HDL cholesterol concentrations in humans: a meta-analysis. Eur J Clin Nutr. 2003;57:940-6.
133. Reynolds K, Chin A, Lees KA, Nguyen A, Bujnowski D, He J. A meta-analysis of the effect of soy protein supplementation on serum lipids. Am J Cardiol. 2006;98:633-40.
134. Hooper L, Kroon PA, Rimm EB, Cohn JS, Harvey I, Le Cornu KA, Ryder JJ, Hall WL, Cassidy A. Flavonoids, flavonoid- rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2008;88:38-50.
135. Anderson JW, Bush HM. Soy protein effects on serum lipoproteins: A quality assessment and meta-analysis of randomized, controlled studies. J. Am. Coll. Nutr. 2011;30:79-91.
136. Jenkins DJ, Mirrahimi A, Srichaikul K, Berryman CE, Wang L, Carleton A, Abdulnour S, Sievenpiper JL, Kendall CW, Kris-Etherton PM. Soy protein reduces serum cholesterol by both intrinsic and food displacement mechanisms. J Nutr. 2010;140:2302S-11.
137. Zhang X, Shu XO, Gao YT, Yang G, Li Q, Li H, Jin F, Zheng W. Soy food consumption is associated with lower risk of coronary heart disease in Chinese women. J Nutr. 2003;133:2874-8.
138. Zhang B, Chen YM, Huang LL, Zhou XX, Chen CG, Ye YB, Su YX. Greater habitual soyfood consumption is associated with decreased carotid intima-media thickness and better plasma lipids in Chinese middle-aged adults. Atherosclerosis. 2008;198:403-11.